Indeed, deletions encompassing both genes (BRCA1 and beclin-1) and deletions of only BRCA1 but not beclin-1 were found in breast and ovarian cancers, which is consistent with BRCA1 loss representing the primary driver mutation in these cancers. This evidence concerns the gene BRCA1 and cancer.